"The genome-based molecular diagnostic company 'Seasoon Biomaterials' recently announced that it is actively developing an innovative cancer diagnosis technology using the genome methylation panel (MPP Panel)...We are continuously conducting research and development for commercialization and clinical application of cancer diagnosis technology through methylation panels, and we are doing our best to provide better diagnosis and treatment to patients..."